Clinical Trials Logo

Myopia, Degenerative clinical trials

View clinical trials related to Myopia, Degenerative.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06250920 Completed - Myopia Clinical Trials

Effect of Virtual Reality-Based Visual Training for Myopia Control in Children

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

To assess the efficacy and safety of virtual reality-based visual training (VRVT) in myopia control among children.

NCT ID: NCT05683535 Completed - Myopia, Progressive Clinical Trials

Adverse Events Related to Low Dose Atropine

AELDA
Start date: June 19, 2018
Phase:
Study type: Observational

Progressive myopia can lead to severe vision loss and is associated with retinal detachment, glaucoma, and other comorbidities. Several studies have shown that off-label, low-dose atropine eye drops slow the progression of myopia. Many eye care providers are now prescribing off-label atropine eye drops for their myopic patients, with the prescribed concentrations varying amongst providers. The purpose of this study is to determine if low-dose atropine eyedrops used daily, cause adverse effects to the eyes. Patients currently using 0.01%, 0.03%, or 0.05% atropine eye drops obtained from compounding pharmacies will be assessed for associated adverse effects.

NCT ID: NCT05372991 Completed - Myopia, Progressive Clinical Trials

Safety, Tolerability and Pharmacodynamics Evaluation of CBT-009 Eye Drop

Start date: July 20, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

This is a Two-Stage Phase 1/2 study to evaluate the safety, tolerability and pharmacodynamics of CBT-009 eye drop in healthy volunteers. CBT-009 has the active ingredient of atropine, which at low doses, has shown to be effective in slowing down myopic deterioration. Current atropine products are prone to degradation once the container is open to the air. ADS Pharmaceutical has developed a novel atropine formulation.

NCT ID: NCT05300321 Completed - Myopia, Progressive Clinical Trials

DIMS-myopia Progression ADN Axial Length Growth

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

To confirm the efficacy of DIMS lenses in controlling myopia progression, we planned a prospective randomized controlled clinical study.

NCT ID: NCT05007626 Completed - Myopia, Progressive Clinical Trials

Near Horizontal Heterophoria in Chinese Children

Start date: January 29, 2017
Phase:
Study type: Observational

This study aimed to assess the association of refraction and axial length with near-horizontal heterophoria in a large population-based study of school-aged Chinese children. The study makes a significant contribution to better know the etiology of myopia progression and ocular axial length development. Further, this study will be of interest to the readership of your journal because its noteworthy finding and which could contribute to guide recommendations for targeted interventions to slow myopia progression.

NCT ID: NCT04806763 Completed - Children, Only Clinical Trials

Myopia Control With Orthokeratology Contact Lenses in Spain

MCOS
Start date: March 1, 2007
Phase: N/A
Study type: Interventional

The purpose of this prospective study is to assess the efficacy, safety and patient-reported outcomes of the Menicon Z Night orthokeratolgy contact lens for reducing myopia progression in children.

NCT ID: NCT04806711 Completed - Children, Only Clinical Trials

Eleven Years of Menicon Z Night Contact Lens Wear in Reducing Myopia Progression in Children

MCOS11
Start date: March 1, 2007
Phase: N/A
Study type: Interventional

To compare axial length growth of white European myopic children wearing Menicon Z Night orthokeratology contact lenses to a control group of distance, single-vision glasses and contact lenses over an 11-year period.

NCT ID: NCT04806698 Completed - Children, Only Clinical Trials

Long-term Efficacy of Orthokeratology Contact Lens Wear in Controlling the Progression of Childhood Myopia

MCOS7
Start date: March 1, 2007
Phase: N/A
Study type: Interventional

To assess the long-term efficacy of the Menicon Z Night orthokeratology contact lens in controlling the progression of childhood myopia

NCT ID: NCT02806830 Completed - Clinical trials for Diabetic Retinopathy

Ocular Discomfort Assessment After Intravitreal Injections

EVAGO
Start date: April 2016
Phase: N/A
Study type: Interventional

In this study, ocular discomfort following intravitreal injection in naïve patients will be studied, as well as the efficacy of wetting agent (Optive eyewash) to prevent ocular discomfort.

NCT ID: NCT01968486 Completed - Clinical trials for Myopia, Degenerative

Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia

Start date: June 2012
Phase: Phase 1
Study type: Interventional

To demonstrate the efficacy of ranibizumab in combination with reduced-fluence verteporfin photodynamic therapy (RF-PDT) in patients with subfoveal choroidal neovascularization secondary to pathologic myopia (PM).